Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 8, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 12, 2026
CFOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-010699
Filed / recorded
Jan 12, 2026, 10:40 PM UTC
Added to OQRO
Oct 6, 2026, 7:37 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
GLOBUS MEDICAL INC
Issuer CIK
1237831
Ticker
GMED
Reporting person
Kyle Kline
Relationship
Officer
Officer title
Senior Vice President, CFO
Security
Stock Option (Right to Buy Class A Common Stock)
Table
Derivative (Table II)
Transaction date
Jan 8, 2026
Transaction code
M
Shares / units
3,594
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
3,906
Ownership form
Direct
Amendment
No
Footnotes from the filing
These options were granted on March 14, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.